ArticleInternational journal of clinical pediatric dentistry
To Analyze the Efficacy of Platelet-rich Plasma in Contrast to Platelet-rich Fibrin along with Synthetic Nanocrystalline Hydroxyapatite and β-tricalcium Phosphate Bone Graft in Regeneration of Bony Defects in Children.
Article in International journal of clinical pediatric dentistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 3 citations in OpenAlex.
- Polymerized injectable platelet-rich fibrin with octacalcium phosphate (bontree®) for treatment of periodontal intrabony defects assessed using CBCT: A randomized controlled clinical trial.Bioinformation · 2026Article
- Bone Regeneration: A Review of Current Treatment Strategies.Journal of clinical medicine · 2025Review
- Bone regeneration using PRF, PRP and β-TCP in bone defects.Bioinformation · 2025Article
- Advances in Bioceramics for Bone Regeneration: A Narrative Review.Biomimetics (Basel, Switzerland) · 2024Review
- Release kinetics of growth factors loaded into β-TCP ceramics in anFrontiers in bioengineering and biotechnology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To analyze the efficacy of platelet-rich plasma (PRP) in contrast to platelet-rich fibrin (PRF) along with synthetic nanocrystalline hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP) bone graft in the regeneration of bone defects in children. Materials and methods: A total of 20 children in whom bone defect was present were selected and divided into two groups of 10. In group I, the bone defect was filled with PRP + nanocrystalline HA with β-TCP and group II, with PRF + nanocrystalline HA with β-TCP. Radiographs using VistaScan with a mesh grid were taken to analyze the bone density and bone regeneration. Clinical evaluation with respect to the color of overlying mucosa, sinus formation, pus discharge, and seepage of bone graft was done. The parameters used to analyze the radiographs included gray scale analysis, residual bone defect calculation in pixels both performed in CorelDraw version 13 software, and radiopaque scoring scale. Results: The mean bone defect density measured using gray scale was higher in the PRF than PRP group. The percentage of bone formation analyzed using residual bone defect calculation and mean radiopaque score revealed that the PRF group showed better outcomes compared to the PRP group. Conclusion: Both PRP and PRF are equally effective in promoting bone regeneration with PRF showing slight superiority over PRP. How to cite this article: Koksi Sangma Shadap NM, Yadav G, Saha S,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.